Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain

Virus Genes

Volumn 37, Issue 1, 2008, Pages 69-80

  Spatz, Stephen J ^a   Rue, Cary ^a   Schumacher, Daniel ^b   Osterrieder, Nikolaus ^b,c  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

584Ap80; Attenuated; BAC20; Gallid herpesvirus type 2; Genome; Marek's disease; Sequence

Indexed keywords

PROTEIN RLORF4; SPACER DNA; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BIOINFORMATICS; BIRD DISEASE; CARCINOGENESIS; CHICKEN; DNA REPLICATION ORIGIN; EMBRYO; GENE DELETION; GENE INSERTION; ILTOVIRUS; IMMUNE RESPONSE; INVERTED REPEAT; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS CULTURE; VIRUS GENOME; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE;

BACTERIA (MICROORGANISMS); GALLID HERPESVIRUS 2;

EID: 45549108280     PISSN: 09208569     EISSN: 1572994X     Source Type: Journal    
DOI: 10.1007/s11262-008-0242-0     Document Type: Article

References (47)

1. S.F. Altschul, W. Gish, W. Miller, E.W. Myers, D.J. Lipman, Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990)
2. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, D.J. Lipman, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402 (1997). doi: 10.1093/nar/25.17.3389
3. A.S. Anderson, M.S. Parcells, R.W. Morgan, The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus. J. Virol. 72, 2548-2553 (1998)
4. P. Brunovskis, L.F. Velicer, The Marek's disease virus (MDV) unique short region: alphaherpesvirus-homologous, fowlpox virus-homologous, and MDV-specific genes. Virology 206, 324-338 (1995). doi: 10.1016/S0042-6822(95)80048-4
5. F. Corpet, Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16, 10881-10890 (1988). doi: 10.1093/nar/16.22.10881
6. C. Denesvre, C. Blondeau, M. Lemesle, Y. Le Vern, D. Vautherot, P. Roingeard, J.F. Vautherot, Morphogenesis of a highly replicative EGFPVP22 recombinant Marek's disease virus in cell culture. J. Virol. 81, 12348-12359 (2007). doi: 10.1128/JVI.01177-07
7. R.L. Dienglewicz, M.S. Parcells, Establishment of a lymphoblastoid cell line using a mutant MDV containing a green fluorescent protein expression cassette. Acta Virol. 43, 106-112 (1999)
8. R.C. Edgar, MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792-1797 (2004). doi: 10.1093/nar/gkh340
9. W. Fuchs, H. Granzow, T.C. Mettenleiter, Functional complementation of UL3.5-negative pseudorabies virus by the bovine herpesvirus 1 UL3.5 homolog. J. Virol. 71, 8886-8892 (1997)
10. W. Fuchs, B.G. Klupp, H. Granzow, H.J. Rziha, T.C. Mettenleiter, Identification and characterization of the pseudorabies virus UL3.5 protein, which is involved in virus egress. J. Virol. 70, 3517-3527 (1996)
11. K.W. Jarosinski, P.H. O'Connell, K.A. Schat, Impact of deletions within the Bam HI-L fragment of attenuated Marek's disease virus on vIL-8 expression and the newly identified transcript of open reading frame LORF4. Virus Genes 26, 255-269 (2003). doi: 10.1023/A:1024447230464
12. K.W. Jarosinski, N. Osterrieder, V.K. Nair, K.A. Schat, Attenuation of Marek's disease virus by deletion of open reading frame RLORF4 but not RLORF5a. J. Virol. 79, 11647-11659 (2005). doi: 10.1128/JVI.79.18.11647-11659.2005
13. K. Katoh, K. Kuma, H. Toh, T. Miyata, MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 33, 511-518 (2005). doi: 10.1093/nar/gki198
14. B.G. Klupp, H. Granzow, W. Fuchs, E. Mundt, T.C. Mettenleiter, Pseudorabies virus UL3 gene codes for a nuclear protein which is dispensable for viral replication. J. Virol. 78, 464-472 (2004). doi: 10.1128/JVI.78.1.464-472. 2004
15. M. Kozak, An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148 (1987). doi: 10.1093/nar/15.20.8125
16. S. Kumar, K. Tamura, M. Nei, MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5, 150-163 (2004). doi: 10.1093/bib/5.2.150
17. H.J. Kung, L. Xia, P. Brunovskis, D. Li, J.-L. Liu, L.F. Lee, Meq: an MDV-specific bZIP transactivator with transforming properties, in Marek's Disease, ed. by K. Hirai (Springer, Berlin, 2000)
18. L.F. Lee, P. Wu, D. Sui, D. Ren, J. Kamil, H.J. Kung, R.L. Witter, The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc. Natl Acad. Sci. U.S.A. 97, 6091-6096 (2000). doi: 10.1073/pnas.97.11.6091
19. H.C. Liu, M. Niikura, J.E. Fulton, H.H. Cheng, Identification of chicken lymphocyte antigen 6 complex, locus E (LY6E, alias SCA2) as a putative Marek's disease resistance gene via a virus-host protein interaction screen. Cytogenet. Genome Res. 102, 304-308 (2003). doi: 10.1159/000075767
20. T. Maray, M. Malkinson, Y. Becker, RNA transcripts of Marek's disease virus (MDV) serotype-1 in infected and transformed cells. Virus Genes 2, 49-68 (1988). doi: 10.1007/BF00569736
21. M. Margulies, M. Egholm, W.E. Altman, S. Attiya, J.S. Bader, L.A. Bemben, J. Berka, M.S. Braverman, Y.J. Chen, Z. Chen, S.B. Dewell, L. Du, J.M. Fierro, X.V. Gomes, B.C. Godwin, W. He, S. Helgesen, C.H. Ho, G.P. Irzyk, S.C. Jando, M.L. Alenquer, T.P. Jarvie, K.B. Jirage, J.B. Kim, J.R. Knight, J.R. Lanza, J.H. Leamon, S.M. Lefkowitz, M. Lei, J. Li, K.L. Lohman, H. Lu, V.B. Makhijani, K.E. McDade, M.P. McKenna, E.W. Myers, E. Nickerson, J.R. Nobile, R. Plant, B.P. Puc, M.T. Ronan, G.T. Roth, G.J. Sarkis, J.F. Simons, J.W. Simpson, M. Srinivasan, K.R. Tartaro, A. Tomasz, K.A. Vogt, G.A. Volkmer, S.H. Wang, Y. Wang, M.P. Weiner, P. Yu, R.F. Begley, J.M. Rothberg, Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376-380 (2005)
22. D.R. Marshall, J.D. Reilly, X. Liu, R.F. Silva, Selection of Marek's disease virus recombinants expressing the Escherichia coli gpt gene. Virology 195, 638-648 (1993). doi: 10.1006/viro.1993.1415
23. M.A. McVoy, D.E. Nixon, S.P. Adler, E.S. Mocarski, Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J. Virol. 72, 48-56 (1998)
24. V. Nair, Evolution of Marek's disease-a paradigm for incessant race between the pathogen and the host. Vet. J. 170, 175-183 (2005)
25. V. Nair, H.-J. Kung, Marek's disease virus oncogenicity: molecular mechanisms, in Marek's Disease: An Emerging Problem, ed. by F. Davidson, V. Nair (Elsevier, Oxford, UK, 2004), pp. 32-48
26. M. Niikura, J. Dodgson, H. Cheng, Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus. Arch. Virol. 151, 537-549 (2005). doi: 10.1007/s00705-005-0633-7
27. M.S. Parcells, S.F. Lin, R.L. Dienglewicz, V. Majerciak, D.R. Robinson, H.C. Chen, Z. Wu, G.R. Dubyak, P. Brunovskis, H.D. Hunt, L.F. Lee, H.J. Kung, Marek's disease virus (MDV) encodes an interleukin-8 homolog (vIL-8): characterization of the vIL-8 protein and a vIL-8 deletion mutant MDV. J. Virol. 75, 5159-5173 (2001). doi: 10.1128/JVI.75.11.5159-5173.2001
28. F. Peng, G. Bradley, A. Tanaka, G. Lancz, M. Nonoyama, Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus. J. Virol. 66, 7389-7396 (1992)
29. Q. Peng, Y. Shirazi, Isolation and characterization of Marek's disease virus (MDV) cDNAs from a MDV-transformed lymphoblastoid cell line: identification of an open reading frame antisense to the MDV Eco-Q protein (Meq). Virology 221, 368-374 (1996). doi: 10.1006/viro.1996.0388
30. Q. Peng, M. Zeng, Z.A. Bhuiyan, E. Ubukata, A. Tanaka, M. Nonoyama, Y. Shirazi, Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. Virology 213, 590-599 (1995). doi: 10.1006/viro.1995.0031
31. J.T. Prigge, V. Majerciak, H.D. Hunt, R.L. Dienglewicz, M.S. Parcells, Construction and characterization of Marek's disease viruses having green fluorescent protein expression tied directly or indirectly to phosphoprotein 38 expression. Avian Dis. 48, 471-487 (2004). doi: 10.1637/7110
32. B.H. Rispens, H. van Vloten, N. Mastenbroek, H.J. Maas, K.A. Schat, Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16, 108-125 (1972). doi: 10.2307/1588905
33. A.A. Schaffer, L. Aravind, T.L. Madden, S. Shavirin, J.L. Spouge, Y.I. Wolf, E.V. Koonin, S.F. Altschul, Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res. 29, 2994-3005 (2001). doi: 10.1093/nar/29.14.2994
34. D. Schumacher, B.K. Tischer, W. Fuchs, N. Osterrieder, Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74, 11088-11098 (2000). doi: 10.1128/JVI.74.23.11088-11098. 2000
35. B. Silva, L.F. Lee, M. Heidari, I. Gimeno, S. Spatz, J. Zelepsky, The role of UL13 in generating cell-free MDV, in 4th International Workshop on the Molecular Pathogenesis of Marek's Disease Virus, ed. by M.S. Parcells, R.W. Morgan, J. Burnside, C.J. Schmidt, E.L. Bernberg, C. Kenny, E. Eppler (University of Delaware, Newark, Delaware, 2006), p. 28
36. R.F. Silva, R.L. Witter, Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage. J. Virol. 54, 690-696 (1985)
37. S.J. Spatz, L. Petherbridge, Y. Zhao, V. Nair, Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus. J. Gen. Virol. 88, 1080-1096 (2007). doi: 10.1099/vir.0.82600-0
38. S.J. Spatz, R.F. Silva, Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1. Virus Genes 35, 41-53 (2007). doi: 10.1007/s11262-006-0024-5
39. S.J. Spatz, R.F. Silva, Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes. Arch. Virol. 152, 1665-1678 (2007). doi: 10.1007/s00705-007-0992-3
40. S.J. Spatz, Y. Zhao, L. Petherbridge, L.P. Smith, S.J. Baigent, V. Nair, Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus. Virus Genes 35, 753-766 (2007)
41. B.L. Strang, N.D. Stow, Circularization of the herpes simplex virus type 1 genome upon lytic infection. J. Virol. 79, 12487-12494 (2005). doi: 10.1128/JVI.79.19.12487-12494.2005
42. B.K. Tischer, D. Schumacher, M. Beer, J. Beyer, J.P. Teifke, K. Osterrieder, K. Wink, V. Zelnik, F. Fehler, N. Osterrieder, A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. J. Gen. Virol. 83, 2367-2376 (2002)
43. E.R. Tulman, C.L. Afonso, Z. Lu, L. Zsak, D.L. Rock, G.F. Kutish, The genome of a very virulent Marek's disease virus. J. Virol. 74, 7980-7988 (2000). doi: 10.1128/JVI.74.17.7980-7988.2000
44. K. Venugopal, Marek's disease: an update on oncogenic mechanisms and control. Res. Vet. Sci. 69, 17-23 (2000). doi: 10.1053/rvsc.2000.0396
45. R.L. Witter, Increased virulence of Marek's disease virus field isolates. Avian Dis. 41, 149-163 (1997). doi: 10.2307/1592455
46. R.L. Witter, Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses. Avian Dis. 46, 925-937 (2002). doi: 10.1637/0005-2086(2002)046[0925:IOSPBV]2.0.CO;2
47. R.L. Witter, B.W. Calnek, C. Buscaglia, I.M. Gimeno, K.A. Schat, Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol. 34, 75-90 (2005). doi: 10.1080/03079450500059255